MEDvidi operates a telehealth platform for mental health treatment, connecting patients with over 100 licensed medical providers across 36 US states. Founded in 2019 and headquartered in San Jose, California, the company conducts more than 120,000 appointments annually, offering personalized treatment plans that include medication management, prescription refills, and ongoing follow-up care.
The company has integrated artificial intelligence into its clinical operations, launching an AI-powered prescribing assistant to support healthcare providers in delivering evidence-based care more efficiently. This technology focus complements its core telehealth infrastructure, which handles the logistical complexity of connecting patients with licensed MDs, DOs, nurse practitioners, and physician assistants.
MEDvidi's scale and geographic reach position it as an established player in the telehealth sector. The platform addresses barriers to mental healthcare access through its remote delivery model and medication management capabilities, serving a patient base distributed across a significant portion of the United States.
